Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia.


Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
05 2023
Historique:
revised: 05 07 2022
received: 07 02 2022
accepted: 22 07 2022
medline: 15 5 2023
pubmed: 12 10 2022
entrez: 11 10 2022
Statut: ppublish

Résumé

Subjective cognitive decline (SCD) and depressive symptoms (DS) frequently co-occur prior to dementia. However, the temporal sequence of their emergence and their combined prognostic value for cognitive decline and dementia is unclear. Temporal relationships of SCD, DS and memory decline were examined by latent difference score modeling in a high-aged, population-based cohort (N = 3217) and validated using Cox-regression of dementia-conversion. In 334 cognitively unimpaired SCD-patients from memory-clinics, we examined the association of DS with cognitive decline and with cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. In the population-based cohort, SCD preceded DS. High DS were associated with increased risk of dementia conversion in individuals with SCD. In SCD-patients from memory-clinics, high DS were associated with greater cognitive decline. CSF Aß42 predicted increasing DS. SCD typically precedes DS in the evolution to dementia. SCD-patients from memory-clinics with DS may constitute a high-risk group for cognitive decline. Subjective cognitive decline (SCD) precedes depressive symptoms (DS) as memory declines. Emerging or persistent DS after SCD reports predict dementia. In SCD patients, more amyloid pathology relates to increasing DS. SCD patients with DS are at high risk for symptomatic progression.

Identifiants

pubmed: 36218120
doi: 10.1002/alz.12785
doi:

Substances chimiques

Biomarkers 0
Amyloid beta-Peptides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2056-2068

Informations de copyright

© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Cherbuin N, Kim S, Anstey KJ. Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis. BMJ Open. 2015;5:e008853. doi:10.1136/bmjopen-2015-008853
Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130(6):439-451. doi:10.1111/acps.12336
Wolfsgruber S, Kleineidam L, Wagner M, et al. Differential risk of incident Alzheimer's disease dementia in stable versus unstable patterns of subjective cognitive decline. J Alzheimer's Dis. 2016;54:1135-1146.
Roehr S, Villringer A, Angermeyer MC, Luck T, Riedel-Heller SG. Outcomes of stable and unstable patterns of subjective cognitive decline - Results from the Leipzig longitudinal study of the aged (LEILA75+). BMC Geriatr. 2016;16:1-8.
Kaup AR, Byers AL, Falvey C, et al. Trajectories of depressive symptoms in older adults and risk of dementia. JAMA Psychiatry. 2016;73:525-531. doi:10.1001/jamapsychiatry.2016.0004
Mirza SS, Wolters FJ, Swanson SA, et al. 10-year trajectories of depressive symptoms and risk of dementia: a population-based study. Lancet Psychiatry 2016;3(7):628-635. doi:10.1016/S2215-0366(16)00097-3
Hill NL, Mogle J, Wion R, et al. Subjective cognitive impairment and affective symptoms: a systematic review. Gerontologist. 2016;56:e109-27. doi:10.1093/geront/gnw091
Jessen F, Amariglio RE, Buckley RF, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19(3):271-278. doi:10.1016/S1474-4422(19)30368-0
McWhirter L, Ritchie C, Stone J, Carson A. Functional cognitive disorders: a systematic review. Lancet Psychiatry. 2020;7(2):191-207. doi:10.1016/S2215-0366(19)30405-5
Topiwala A, Suri S, Allan C, et al. Subjective Cognitive complaints given in questionnaire: relationship with brain structure, cognitive performance and self-reported depressive symptoms in a 25-year retrospective cohort study. Am J Geriatr Psychiatry. 2021;29:217-226. doi:10.1016/j.jagp.2020.07.002
Liew TM. Depression, subjective cognitive decline, and the risk of neurocognitive disorders. Alzheimer's Res Ther. 2019;11:70. doi:10.1186/s13195-019-0527-7
Jessen F, Wiese B, Bachmann C, et al. Prediction of dementia by subjective memory impairment effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010;67:414-422. doi:10.1001/archgenpsychiatry.2010.30
Grimm KJ, Mazza GL, Mazzocco MMM. Advances in methods for assessing longitudinal change. Educ Psychol. 2016;51:342-353. doi:10.1080/00461520.2016.1208569
McArdle JJ. Latent variable modeling of differences and changes with longitudinal data. Annu Rev Psychol. 2009;60:577-605. doi:10.1146/annurev.psych.60.110707.163612
Jorm AF, Christensen H, Korten AE, Jacomb PA, Henderson AS. Memory complaints as a precursor of memory impairment in older people: a longitudinal analysis over 7-8 years. Psychol Med. 2001;31:441-449. doi:10.1017/s0033291701003245
Brailean A, Steptoe A, Batty GD, Zaninotto P, Llewellyn DJ. Are subjective memory complaints indicative of objective cognitive decline or depressive symptoms? Findings from the english longitudinal study of ageing. J Psychiatr Res. 2019;110:143-151. doi:10.1016/j.jpsychires.2018.12.005
Hill NL, Bhargava S, Bratlee-Whitaker E, Turner JR, Brown MJ, Mogle J. Longitudinal relationships between subjective cognitive decline and objective memory: depressive symptoms mediate between-person associations. J Alzheimer's Dis. 2021:83(4):1623-1636. doi:10.3233/JAD-210230
Hülür G, Hertzog C, Pearman A, Ram N, Gerstorf D. Longitudinal associations of subjective memory with memory performance and depressive symptoms: between-person and within-person perspectives. Psychol Aging. 2014;29:814-827. doi:10.1037/a0037619
Zimprich D, Martin M, Kliegel M. Subjective cognitive complaints, memory performance, and depressive affect in old age: a change-oriented approach. Int J Aging Hum Dev. 2003;57(4):339-366. doi:10.2190/G0ER-ARNM-BQVU-YKJN
Aichele S, Ghisletta P, Corley J, et al. Fluid Intelligence predicts change in depressive symptoms in later life: the Lothian birth cohort 1936. Psychol Sci. 2018;29(12):1984-1995. doi:10.1177/0956797618804501
Aichele S, Ghisletta P. Memory deficits precede increases in depressive symptoms in later adulthood. J Gerontol B Psychol Sci Soc Sci. 2019;74(6):943-953. doi:10.1093/geronb/gbx183
Jajodia A, Borders A. Memory predicts changes in depressive symptoms in older adults: a bidirectional longitudinal analysis. J Gerontol B Psychol Sci Soc Sci. 2011;66B(5):571-581. doi:10.1093/geronb/gbr035
Petersen I, McGue M, Tan Q, Christensen K, Christiansen L. Change in depression symptomatology and cognitive function in twins: a 10-year follow-up study. Twin Res Hum Genet. 2016;19(2):104-111. doi:10.1017/thg.2016.3
Bunce D, Batterham PJ, Christensen H, MacKinnon AJ. Causal associations between depression symptoms and cognition in a community-based cohort of older adults. Am J Geriatr Psychiatry. 2014;22(12):1583-1591. doi:10.1016/j.jagp.2014.01.004
Desai R, Charlesworth GM, Brooker HJ, et al. Temporal relationship between depressive symptoms and cognition in mid and late life: a longitudinal cohort study. J Am Med Dir Assoc. 2020;21(8):1108-1113. doi:10.1016/j.jamda.2020.01.106
Bhang I, Mogle J, Hill N, Whitaker EB, Bhargava S. Examining the temporal associations between self-reported memory problems and depressive symptoms in older adults. Aging Ment Heal. 2020;24(11):1864-1871. doi:10.1080/13607863.2019.1647135
Mogle J, Hill NL, Bhargava S, Bell TR, Bhang I. Memory complaints and depressive symptoms over time: a construct-level replication analysis. BMC Geriatr. 2020;20:57. doi:10.1186/s12877-020-1451-1
Hill NL, Mogle J, Bhargava S, et al. Longitudinal relationships among depressive symptoms and three types of memory self-report in cognitively intact older adults. Int Psychogeriatrics. 2020;32:719-732. doi:10.1017/S104161021900084X
Kuhn E, Moulinet I, Perrotin A, et al. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time. Alzheimers Res Ther. 2019;11:1-16.
Rodriguez-Gomez O, Abdelnour C, Jessen F, Valero S, Boada M. Influence of sampling and recruitment methods in studies of subjective cognitive decline. J Alzheimer's Dis. 2015;48:S99-107.
Kornhuber J, Schmidtke K, Frölich L, et al. Early and differential diagnosis of dementia and mild cognitive impairment. Dement Geriatr Cogn Disord. 2009;27:404-417. doi:10.1159/000210388
Jack CR, Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer's disease. Alzheimer's dement. 2018;14(4):535-562. doi:10.1016/j.jalz.2018.02.018
Creese B, Ismail Z. Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer's disease. Alzheimers Res Ther. 2022;14:1-5.
Young AL, Marinescu RV, Oxtoby NP, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun. 2018;9:1-16
Donovan NJ, Locascio JJ, Marshall GA, et al. Longitudinal association of amyloid beta and anxious-depressive symptoms in cognitively normal older adults. Am J Psychiatry. 2018;175:530-537. doi:10.1176/appi.ajp.2017.17040442
Marchant NL, Barnhofer T, Coueron R, et al. Effects of a Mindfulness-based intervention versus health self-management on subclinical anxiety in older adults with subjective cognitive decline: the SCD-well randomized superiority trial. Psychother Psychosom. 2021;90:341-350.
Hanseeuw BJ, Scott MR, Sikkes SAM, et al. Evolution of anosognosia in alzheimer's disease and its relationship to amyloid. Ann Neurol. 2020;87:267-280.
Cole SR, Platt RW, Schisterman EF, et al. Illustrating bias due to conditioning on a collider. Int J Epidemiol. 2010;39(2):417-420. doi:10.1093/ije/dyp334
Bondi MW, Edmonds EC, Jak AJ, et al. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42:275-289. doi:10.3233/JAD-140276
Molinuevo JL, Rabin LA, Amariglio R, et al. Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. 2017;13(3):296-311. doi:10.1016/j.jalz.2016.09.012
Mistridis P, Egli SC, Iverson GL, et al. Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB). Eur Arch Psychiatry Clin Neurosci. 2015;265:407-417. doi:10.1007/s00406-014-0571-z
Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5:165-173. doi:10.1300/J018v05n01_09
Schmid NS, Ehrensperger MM, Berres M, Beck IR, Monsch AU. The extension of the German CERAD neuropsychological assessment battery with tests assessing subcortical, executive and frontal functions improves accuracy in dementia diagnosis. Dement Geriatr Cogn Dis Extra. 2014;4:322-334. doi:10.1159/000357774
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389. doi:10.1192/bjp.134.4.382
Li D, Iddi S, Aisen PS, Thompson WK, Donohue MC, Initiative ADN. The relative efficiency of time-to-progression and continuous measures of cognition in presymptomatic Alzheimer's disease. Alzheimer's. Dement Transl Res Clin Interv. 2019;5:308-318.
Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141(11):1356-1364. doi:10.1176/ajp.141.11.1356
Papp KV, Rentz DM, Orlovsky I, Sperling RA, Mormino EC. Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: the PACC5. Alzheimer's. Dement Transl Res Clin Interv. 2017;3:668-677.
VanderWeele TJ, Knol MJ. A tutorial on interaction. Epidemiol Method. 2014;3:33-72.
Proust-Lima C, Philipps V, Liquet B. Estimation of extended mixed models using latent classes and latent processes: the R package lcmm. J Stat Softw. 2017. doi:10.18637/jss.v078.i02
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289-300.

Auteurs

Luca Kleineidam (L)

Department, of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Michael Wagner (M)

Department, of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Jannis Guski (J)

Department, of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Steffen Wolfsgruber (S)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Lisa Miebach (L)

Department, of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.

Horst Bickel (H)

Department of Psychiatry, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Services Research, Hamburg Center for Health Economics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Siegfried Weyerer (S)

Central Institute of Mental Health, Medical Faculty, Mannheim/Heidelberg University, Heidelberg, Germany.

Dagmar Lühmann (D)

Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Hanna Kaduszkiewicz (H)

Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Institute of General Practice, Medical Faculty, University of Kiel, Kiel, Germany.

Melanie Luppa (M)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Susanne Röhr (S)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Michael Pentzek (M)

Institute of General Practice (ifam), Centre for Health and Society (chs), Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.

Birgitt Wiese (B)

Center for Information Management, Hannover Medical School, Hannover, Germany.

Wolfgang Maier (W)

Department, of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Martin Scherer (M)

Department of Primary Medical Care, Center for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Johannes Kornhuber (J)

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.

Oliver Peters (O)

Department of Psychiatry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
DZNE, German Center for Neurodegenerative Diseases, Berlin, Germany.

Lutz Frölich (L)

Department of Geriatric Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany.

Jens Wiltfang (J)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany.
Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.

Piotr Lewczuk (P)

Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
Department of Neurodegeneration Diagnostics, Medical University of Białystok, Białystok, Poland.
Department of Biochemical Diagnostics, University Hospital of Białystok, Białystok, Poland.

Michael Hüll (M)

Department of Psychiatry and Psychotherapy, University of Freiburg, and Clinic for Geriatric Psychiatry and Psychotherapy, Emmendingen, Germany.

Alfredo Ramirez (A)

Department, of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Cologne, Cologne, Germany.
Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Germany.
Department of Psychiatry and Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, Texas, USA.

Frank Jessen (F)

German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Germany.
Department of Psychiatry and Psychotherapy, University of Cologne, Medical Faculty, Cologne, Germany.

Steffi G Riedel-Heller (SG)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Kathrin Heser (K)

Department, of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH